This medication does not cure this condition, but it helps decrease symptoms such as
Drug class: Sulfonamides - Disease-Modifying Antirheumatic Drugs - DMARDS VA class: AM650 CAS number: 599-79-1
Sulfasalazine (brand name: Azulfidine) and the 5-aminosalicylate drugs (sample brand names: Delzicol, Asacol HD, Pentasa, Salofalk, Dipentum, Colazal
About sulfasalazine
Drug Class: DMARDs Brand Names: Azulfidine, Azulfidine EN-Tabs, Sulfazine, Sulfazine EC Dosages 500 mg to 3 grams daily in two to four doses
com
Azulfidine (sulfasalazine delayed release tablets) is an anti-inflammatory agent and immunomodulatory agent used to treat moderate to severe ulcerative colitis
5 to 2 days to get sulfasalazine out of your system
Read this chapter of Davis's Drug Guide for Rehabilitation Professionals online now, exclusively on F
1–2 g 4 times a day until remission occurs
Rash, fever, and swollen lymph nodes
com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products
1 interaction
Detectable serum concentrations of SSZ have been found in healthy subjects within 90 minutes after the ingestion
Drug Interaction Classification
Sulfasalazine is an anti-inflammatory drug structurally related to salicylates and other non-steroidal anti-inflammatory drugs
Sulfasalazine also may prevent joint damage and decrease the
Results can vary due to many factors, including your age, health, how fast you metabolize, and drug route and dose
6 L
Follow your doctor’s directions
The dose is usually 30 to 50 milligrams (mg) per kilogram (kg) of body weight per day, divided into 2 doses
DMARDs include older drugs and newer biologic DMARDs that better target disease
A small percentage of the absorbed sulfasalazine is excreted in the urine and the rest via the bile into the small intestine (enterohepatic circulation)
Contraindication: Sulfasalazine tablets are contraindicated in: Patients with intestinal or urinary obstruction,porphyria as sulfonamides have been reported to precipitate an acute attack, or patients hypersensitive to Sulfasalazine, its metabolites
The 5-aminosalicylic acid (5-ASA) medications were developed because many patients were Ulcerative colitis
Therapeutic Classification: Anti-inflammatory agent and/or immunomodulatory agent